Effectiveness of Renal Denervation in Resistant Hypertension: A Meta-Analysis of 11 Controlled Studies

High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension
Marco PappaccogliFranco Veglio

Abstract

Early uncontrolled studies reported large blood pressure reductions in subjects with resistant hypertension treated with renal denervation, however these results were not confirmed in several of the latest publications. The aim of the current study was to evaluate the effectiveness of RDN in controlled studies comparing RDN to either a sham procedure or to medical therapy. Only controlled studies were included in the analysis. Both the unadjusted and control-adjusted BP changes were calculated. We identified 11 publications of which only 3 were double-blinded RCTs with a sham control, while 8 were open label studies where the control group was treated with medical therapy. Only 2 studies assessed adherence to medical therapy with robust methodologies. Office BP reduction (- 18/8 mmHg) significantly overestimated ABPM change (- 9/- 5 mmHg), with high heterogeneity between the included studies. When the treatment effect was adjusted for the BP change in the control group, BP changes became non significant (ABPM: - 1.8 for systolic BP [95% CI - 4.5 to 0.9] and - 0.6 for diastolic BP [95% CI - 2.3 to 1.2]). These results were confirmed when only the sham-controlled studies were analysed. In spite of promising results in early repor...Continue Reading

References

Aug 22, 2003·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·Michel BurnierHans R Brunner
Aug 14, 2012·Lancet·Stéphane LaurentMurray Esler
Dec 10, 2013·Journal of the American College of Cardiology·George Bakris, Sandeep Nathan
Dec 24, 2013·Blood Pressure·Giuseppe ManciaFaiez Zannad
Feb 1, 2014·International Journal of Cardiology·James P HowardDarrel P Francis
Apr 1, 2014·The New England Journal of Medicine·Deepak L BhattUNKNOWN SYMPLICITY HTN-3 Investigators
May 27, 2014·Journal of the American College of Cardiology·George L BakrisUNKNOWN SYMPLICITY HTN-3 Investigators
Nov 7, 2014·Journal of Hypertension·Alexandre PersuUNKNOWN European Network COordinating research on Renal Denervation (ENCOReD) consortium
Apr 4, 2015·Journal of the American College of Cardiology·George L BakrisUNKNOWN SYMPLICITY HTN-3 Investigators
Apr 29, 2015·Circulation Journal : Official Journal of the Japanese Circulation Society·Kazuomi KarioUNKNOWN SYMPLICITY HTN-Japan Investigators
Jul 22, 2015·Blood Pressure·Fadl Elmula M Fadl ElmulaUNKNOWN European Network Coordinating Research On Renal Denervation (ENCOReD) Consortium
May 11, 2016·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Franco RabbiaFranco Veglio

❮ Previous
Next ❯

Citations

Apr 15, 2020·Nature Reviews. Cardiology·Lucas LauderFelix Mahfoud
Sep 12, 2018·Current Hypertension Reports·Raymond R Townsend, Paul A Sobotka
Nov 18, 2020·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Roland E Schmieder
Nov 14, 2020·Current Opinion in Nephrology and Hypertension·Agnes Bosch, Roland E Schmieder
Dec 16, 2021·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Aikaterini DamianakiMichel Burnier
Jan 15, 2022·Der Internist·Kristina StriepeRoland Schmieder

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.